课题基金 / 基金详情

Diversity-Oriented Synthesis of Stapled Peptides

Diversity-Oriented Synthesis of Stapled Peptides
钉合肽的多样性导向合成
批准号:
EP/P020291/1
负责人:
David Spring
金额:
$153.59万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

David Spring的其他基金

相似基金

相关文献

中文摘要
翻译
制药业历来在开发针对酶和受体蛋白等靶标的疗法方面取得了巨大成功。近年来,人们看到了探索新的、更具挑战性的生物目标的转变。蛋白质-蛋白质相互作用(PPI)是新的潜在药物靶点的一个令人难以置信的丰富来源,因为它们与包括各种癌症在内的人类疾病有着无可辩驳的联系。不幸的是,PPI仍然是一大类未被充分利用的药物靶点,因为传统的小分子方法通常不能理想地抑制PPI界面。构象受限的多肽(通常被称为“装订多肽”)已经成为一种很有前途的策略,可以解决这些历史上“不可用药”的靶点,并为许多疾病的复杂机制提供新的有价值的见解,这些疾病具有高度未得到满足的医疗需求。这项提议旨在开发一个新的支持平台,用于高效生产各种构象受限的多肽,这些多肽具有与制药行业直接相关的量身定制的特性。这项技术将在其效率、适应性和实施简单性方面出类拔萃,并将代表着从目前的化学方法到获得具有特定化学/生物特征的限制性多肽的重大变化。拟议的工作有可能为快速发现和优化下一代癌症疗法定义一项一般战略,并为化学生物学研究提供大量新的高质量探针。
英文摘要
The pharmaceutical industry has historically had great success in developing therapeutics against targets such as enzymes and receptor proteins. Recent years have witnessed a shift towards exploring new and more challenging biological targets. Protein-protein interactions (PPIs) represent an incredibly rich source of new potential drug targets, as they are irrefutably linked to human diseases, including various cancers. Unfortunately, PPIs remain a large and underexploited class of drug-targets as traditional small molecule approaches are often not ideal for inhibiting PPI interfaces. Conformationally-constrained peptides (often referred to as 'stapled peptides') has emerged as a promising strategy to address these historically 'undruggable' targets and provide new and valuable insights into the complex mechanisms that underlie many diseases with high unmet medical needs. This proposal aims to develop a new enabling platform for the efficient production of diverse conformationally-constrained peptides with tailored properties that are directly relevant to the pharmaceutical industry. The technique will be exceptional in its efficiency, adaptability and simplicity of implementation, and would represent a major step-change from current chemistry approaches to access constrained peptides with specific chemical/biological profiles. The proposed work has the potential to define a general strategy for the rapid discovery and optimisation of next-generation cancer therapeutics, and deliver a vast array of new high-quality probes for chemical biology studies.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
A fragment-based approach leading to the discovery of inhibitors of CK2a with a novel mechanism of action.
基于片段的方法导致发现具有新颖作用机制的 CK2a 抑制剂。
DOI: 10.17863/cam.92230
发表时间: 2022
期刊:
影响因子: --
作者: [Brear P]
通讯作者: Brear P
DOI: 10.1186/s12870-021-03010-9
发表时间: 2021-06-17
期刊: BMC plant biology
影响因子: 5.3
作者: [Bourdon M, Gaynord J, Müller KH, Evans G, Wallis S, Aston P, Spring DR, Wightman R]
通讯作者: Wightman R
DOI: 10.1039/c9sc06410a
发表时间: 2020-01-27
期刊: Chemical science
影响因子: 8.4
作者: [Bargh JD, Walsh SJ, Isidro-Llobet A, Omarjee S, Carroll JS, Spring DR]
通讯作者: Spring DR
DOI: 10.3390/molecules26071977
发表时间: 2021-03-31
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者: [Atkinson EL, Iegre J, Brear PD, Zhabina EA, Hyvönen M, Spring DR]
通讯作者: Spring DR
Development of an Integrated Microfluidic Platform for the Identification of Therapeutic Peptides for Unmet Medical Needs
  • 批准号:
    EP/W001233/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.66万
  • 财政年份:
    2022
  • 负责人:
    David Spring
  • 依托单位:
Restricted Diversity; Constrained Diversity-Oriented Synthesis
  • 批准号:
    EP/J016012/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $196.46万
  • 财政年份:
    2012
  • 负责人:
    David Spring
  • 依托单位:
Diversity-Oriented Synthesis and Chemical Genetics of New Antibacterials
  • 批准号:
    EP/C011376/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $37.08万
  • 财政年份:
    2006
  • 负责人:
    David Spring
  • 依托单位:
Diversity Oriented Synthesis of New Antibacterials
  • 批准号:
    EP/C01135X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $28.36万
  • 财政年份:
    2006
  • 负责人:
    David Spring
  • 依托单位:
国内基金
海外基金
炭包覆纳米晶的"Oriented Attachment"生长及其多维结构构筑
  • 批准号:
    51572015
  • 项目类别:
    面上项目
  • 资助金额:
    64.0万元
  • 批准年份:
    2015
  • 负责人:
    周继升
  • 依托单位: